Felipe Duran - 19 Mar 2026 Form 4 Insider Report for iBio, Inc. (IBIO)

Reporting relationship: Chief Financial Officer
Issuer ticker: IBIO
Reported as of: 19 Mar 2026
Net transaction value: +$50,132
SEC form: 4
Accepted by SEC: 23 Mar 2026, 07:31:15 UTC
Prior SEC filing: 30 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Felipe Duran

Key filing fact

Felipe Duran filed Form 4 for iBio, Inc. (IBIO) on 23 Mar 2026.

Key facts

This page summarizes Felipe Duran's Form 4 filing for iBio, Inc. (IBIO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 Mar 2026, 07:31.

Change

Previous filing in this sequence was filed on 30 Jan 2026.
Current net transaction value: +$50,132.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001964267 Primary reporting owner

Duran Felipe

Relationship: Chief Financial Officer
Address: C/O IBIO, INC., 11750 SORRENTO VALLEY, ROAD, SUITE 200, SAN DIEGO
Signature: /s/ Felipe Duran
Signature date: 23 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IBIO transaction

Common Stock

Purchase

Transaction value: $50,132
Shares: +24,835
Change %: +223%
Price: $2.02
Shares after: 35,974
Date: 19 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of the Issuer's common stock purchased by the Reporting Person in multiple transactions at prices ranging from $2.01 through $2.02, inclusive, having a weighted average price as shown in column 4 of $2.0186. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range.